COLLPLANT BIOTECHNOLOGIES LT shareholders Q2 2023

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

COLLPLANT BIOTECHNOLOGIES LT shareholders Q2 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,686,8429.21%
VILLERE ST DENIS J & CO LLC 292,723$2,388,6190.17%
PINNACLE ASSOCIATES LTD 484,653$3,954,7680.07%
FNY Investment Advisers, LLC 1,539$120.02%
BENJAMIN F. EDWARDS & COMPANY, INC. 49,210$3990.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,171$187,9170.00%
BROWN ADVISORY INC 73,849$602,6080.00%
Geneos Wealth Management Inc. 750$6,0830.00%
Focused Wealth Management, Inc 242$1,9750.00%
UBS Group AG 6,548$53,4320.00%
NewEdge Advisors, LLC 500$4,0800.00%
BANK OF AMERICA CORP /DE/ 7,389$60,2940.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,600$29,3760.00%
FIRST MANHATTAN CO. LLC. 100$8160.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 121$9870.00%
NATIONAL BANK OF CANADA /FI/ 250$1,9780.00%
External links

This page lists COLLPLANT BIOTECHNOLOGIES LT's shareholders in Q2 2023. To view COLLPLANT BIOTECHNOLOGIES LT's shareholder history, click here.